A panel during the Academy of Managed Care Pharmacy’s (AMCP) recent meeting in San Diego, California, discussed how rapid-cycle analytics and real-world evidence can both bolster health care and cut costs.
The discussion was led by Horizon BCBS’s Saira Jan, Harvard Medical School’s Sebastian Schneeweiss and Aetion’s Sara Eapen.
Jan noted that payers generally favor evidence generated from their own membership, while Schneeweiss added that rapid-cycle analytics and real-world evidence should be utilized in tandem to strengthen decision-making.
Key barriers to using RWE in decision-making, Schneeweiss said, include inexperience in real-world trial settings and untimely data availability, among other things.
To read more about the panel discussion, click here.